These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15120347)

  • 21. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.
    Wood E; Kerr T; Small W; Li K; Marsh DC; Montaner JS; Tyndall MW
    CMAJ; 2004 Sep; 171(7):731-4. PubMed ID: 15451834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime.
    Wood E; Tyndall MW; Lai C; Montaner JS; Kerr T
    Subst Abuse Treat Prev Policy; 2006 May; 1():13. PubMed ID: 16722550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a medically supervised injection facility among street youth.
    Hadland SE; DeBeck K; Kerr T; Nguyen P; Simo A; Montaner JS; Wood E
    J Adolesc Health; 2014 Nov; 55(5):684-9. PubMed ID: 24925493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use.
    Collins CL; Kerr T; Kuyper LM; Li K; Tyndall MW; Marsh DC; Montaner JS; Wood E
    J Urban Health; 2005 Jun; 82(2):276-84. PubMed ID: 15872188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
    Milloy MJ; Kerr T; Mathias R; Zhang R; Montaner JS; Tyndall M; Wood E
    Am J Drug Alcohol Abuse; 2008; 34(4):499-509. PubMed ID: 18584579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.
    Reddon H; Wood E; Tyndall M; Lai C; Hogg R; Montaner J; Kerr T
    AIDS Educ Prev; 2011 Oct; 23(5):412-22. PubMed ID: 22010805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should North America's first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?
    Jozaghi E; Andresen MM
    Harm Reduct J; 2013 Feb; 10():1. PubMed ID: 23414093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injection drug use cessation and use of North America's first medically supervised safer injecting facility.
    DeBeck K; Kerr T; Bird L; Zhang R; Marsh D; Tyndall M; Montaner J; Wood E
    Drug Alcohol Depend; 2011 Jan; 113(2-3):172-6. PubMed ID: 20800976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale to evaluate medically supervised safer smoking facilities for non-injection illicit drug users.
    Collins CL; Kerr T; Tyndall MW; Marsh DC; Kretz PS; Montaner JS; Wood E
    Can J Public Health; 2005; 96(5):344-7. PubMed ID: 16238151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States.
    Semaan S; Fleming P; Worrell C; Stolp H; Baack B; Miller M
    Drug Alcohol Depend; 2011 Nov; 118(2-3):100-10. PubMed ID: 21515001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users.
    Wood E; Tyndall MW; Zhang R; Montaner JS; Kerr T
    Addiction; 2007 Jun; 102(6):916-9. PubMed ID: 17523986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation.
    Krüsi A; Small W; Wood E; Kerr T
    AIDS Care; 2009 May; 21(5):638-44. PubMed ID: 19444673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
    Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
    Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.
    Hyshka E; Bubela T; Wild TC
    Addiction; 2013 Mar; 108(3):468-76. PubMed ID: 23286831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility.
    Milloy MJ; Kerr T; Tyndall M; Montaner J; Wood E
    PLoS One; 2008 Oct; 3(10):e3351. PubMed ID: 18839040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Condom use among injection drug users accessing a supervised injecting facility.
    Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
    Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public injecting among a cohort of injecting drug users in Vancouver, Canada.
    DeBeck K; Small W; Wood E; Li K; Montaner J; Kerr T
    J Epidemiol Community Health; 2009 Jan; 63(1):81-6. PubMed ID: 18628270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility.
    Fast D; Small W; Wood E; Kerr T
    Harm Reduct J; 2008 Oct; 5():32. PubMed ID: 18957139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.